↓ Skip to main content

Ketamine for management of acute exacerbations of asthma in children

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs
1 blog
twitter
14 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page
googleplus
1 Google+ user
f1000
1 research highlight platform

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
105 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ketamine for management of acute exacerbations of asthma in children
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd009293.pub2
Pubmed ID
Authors

Kana R Jat, Deepak Chawla

Abstract

Asthma is the most common chronic disease in children, and children with asthma frequently visit the paediatric emergency departments with acute exacerbations. Some of these children fail to respond to standard therapy (aerosol beta(2)-agonist with or without aerosol anticholinergic and oral or parenteral corticosteroids) for acute asthma leading to prolonged emergency department stay, hospitalisation, morbidity (e.g. barotrauma, intubation) and death, albeit rarely. Ketamine may relieve bronchospasm and is a potentially promising therapy for children with acute asthma who fail to respond to standard treatment.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Denmark 1 <1%
Mexico 1 <1%
Unknown 101 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 18%
Researcher 17 16%
Student > Bachelor 14 13%
Other 11 10%
Unspecified 9 9%
Other 35 33%
Readers by discipline Count As %
Medicine and Dentistry 62 59%
Unspecified 15 14%
Nursing and Health Professions 11 10%
Social Sciences 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 7 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2019.
All research outputs
#822,948
of 13,615,090 outputs
Outputs from Cochrane database of systematic reviews
#2,576
of 10,678 outputs
Outputs of similar age
#6,668
of 117,301 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 100 outputs
Altmetric has tracked 13,615,090 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,678 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,301 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.